Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
719
-
Total 13F shares, excl. options
-
68,897,668
-
Shares change
-
+1,303,728
-
Total reported value, excl. options
-
$32,124,610,400
-
Value change
-
+$628,245,813
-
Put/Call ratio
-
1.35%
-
Number of buys
-
360
-
Number of sells
-
-287
-
Price
-
$469.01
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2021
802 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2021.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 719 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68,897,668 shares
of 71,941,794 outstanding shares and own 95.77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,633,853 shares), BlackRock Inc. (8,094,288 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,241,901 shares), STATE STREET CORP (3,455,709 shares), FRANKLIN RESOURCES INC (2,848,869 shares), APG Asset Management N.V. (2,547,368 shares), WCM INVESTMENT MANAGEMENT, LLC (1,514,826 shares), GEODE CAPITAL MANAGEMENT, LLC (1,382,016 shares), BROWN ADVISORY INC (1,338,591 shares), and FMR LLC (1,302,588 shares).
This table shows the top 719 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.